Q1 2024 |
43 |
$5.13B |
+$998M |
-$786M |
+$213M |
THC, CI, CTVA, UHS, GPN, ALIT |
13F-HR |
5/15/2024, 04:23 PM |
Q4 2023 |
41 |
$4.29B |
+$805M |
-$699M |
+$105M |
CI, THC, DXC, UHS, GPN, CLVT |
13F-HR |
2/14/2024, 04:26 PM |
Q3 2023 |
61 |
$4.42B |
+$831M |
-$496M |
+$335M |
SPY, THC, CI, UHS, GPN, DXC |
13F-HR |
11/14/2023, 04:30 PM |
Q2 2023 |
62 |
$4.44B |
+$524M |
-$1.14B |
-$611M |
CI, SPY, THC, DXC, UHS, GPN |
13F-HR |
8/14/2023, 05:13 PM |
Q1 2023 |
54 |
$4.56B |
+$746M |
-$385M |
+$361M |
SPY, CI, THC, FI, GPN, DXC |
13F-HR |
5/15/2023, 04:18 PM |
Q4 2022 |
53 |
$4.51B |
+$911M |
-$460M |
+$452M |
CI, THC, SPY, DXC, FI, MCK |
13F-HR |
2/14/2023, 03:21 PM |
Q3 2022 |
54 |
$4B |
+$667M |
-$251M |
+$417M |
CI, THC, FI, DXC, GPN, MCK |
13F-HR |
11/14/2022, 03:12 PM |
Q2 2022 |
55 |
$4B |
+$675M |
-$163M |
+$512M |
CI, THC, GPN, DXC, MCK, FI |
13F-HR |
8/11/2022, 04:15 PM |
Q1 2022 |
60 |
$4.94B |
+$1.1B |
-$691M |
+$409M |
THC, CI, GPN, MCK, DXC, FI |
13F-HR |
5/16/2022, 04:43 PM |
Q4 2021 |
56 |
$4.69B |
+$418M |
-$1.07B |
-$655M |
THC, MCK, BHC, GPN, CI, BAX |
13F-HR |
2/14/2022, 04:05 PM |
Q3 2021 |
2 |
$55.1M |
|
|
|
QSI, EVLV |
NEW HOLDINGS |
2/18/2022, 04:16 PM |
Q3 2021 |
61 |
$5.51B |
+$770M |
-$628M |
+$142M |
THC, BHC, MCK, CI, COR, GPN |
13F-HR |
11/15/2021, 03:38 PM |
Q2 2021 |
63 |
$6.03B |
+$1.23B |
-$1.04B |
+$191M |
THC, BHC, CI, MCK, DXC, PARA |
RESTATEMENT |
2/18/2022, 04:16 PM |
Q1 2021 |
63 |
$5.9B |
+$1.79B |
-$833M |
+$962M |
THC, BHC, CI, MCK, DXC, TAK |
13F-HR |
5/17/2021, 04:06 PM |
Q4 2020 |
56 |
$4.36B |
+$715M |
-$476M |
+$238M |
THC, BHC, TAK, DXC, CI, HCA |
13F-HR |
2/16/2021, 03:16 PM |
Q3 2020 |
45 |
$3.19B |
+$122M |
-$777M |
-$655M |
THC, TAK, BHC, CI, HCA, MCK |
13F-HR |
11/16/2020, 03:09 PM |
Q2 2020 |
44 |
$3.63B |
+$520M |
-$1.09B |
-$570M |
THC, TAK, BHC, CI, HCA, DXC |
13F-HR |
8/14/2020, 04:06 PM |
Q1 2020 |
44 |
$3.68B |
+$239M |
-$3.17B |
-$2.93B |
TAK, THC, CI, BHC, HCA, MCK |
13F-HR |
5/15/2020, 04:07 PM |
Q4 2019 |
50 |
$11.4B |
+$2.01B |
-$1.37B |
+$640M |
HCA, CI, THC, PARA, TAK, IQV |
13F-HR |
2/14/2020, 03:18 PM |
Q3 2019 |
49 |
$9.51B |
+$1.05B |
-$1.38B |
-$337M |
CI, HCA, MCK, IQV, TAK, THC |
13F-HR |
11/14/2019, 03:07 PM |
Q2 2019 |
46 |
$11B |
+$1.08B |
-$1.12B |
-$32.6M |
CI, HCA, IQV, FMC, MCK, DXC |
13F-HR |
8/14/2019, 04:07 PM |
Q1 2019 |
45 |
$11.2B |
+$2.93B |
-$838M |
+$2.09B |
DXC, FMC, CI, MCK, IQV, HCA |
13F-HR |
5/15/2019, 04:06 PM |
Q4 2018 |
50 |
$10.3B |
+$1.88B |
-$1.81B |
+$67.5M |
SHPG, FMC, IQV, HCA, CVS, CI |
13F-HR |
2/14/2019, 03:12 PM |
Q3 2018 |
58 |
$15.7B |
+$1.99B |
-$1.99B |
-$4.58M |
ESRX, FMC, AET, IQV, MCK, DWDP |
13F-HR |
11/14/2018, 03:09 PM |
Q2 2018 |
50 |
$14.7B |
+$936M |
-$3.07B |
-$2.13B |
SHPG, DWDP, FMC, MCK, THC, IQV |
13F-HR |
8/14/2018, 04:08 PM |
Q1 2018 |
53 |
$17.1B |
+$1.99B |
-$1.77B |
+$222M |
HCA, SHPG, DWDP, FMC, IQV, NWL |
13F-HR |
5/15/2018, 04:07 PM |
Q4 2017 |
58 |
$18.5B |
+$4.5B |
-$2.32B |
+$2.17B |
HCA, DWDP, FMC, SHPG, IQV, FLEX |
13F-HR |
2/14/2018, 03:26 PM |
Q3 2017 |
56 |
$17.2B |
+$3.5B |
-$940M |
+$2.56B |
HCA, DWDP, FMC, SHPG, Q, ELV |
13F-HR |
11/14/2017, 03:18 PM |
Q2 2017 |
52 |
$15.4B |
+$2.67B |
-$2.08B |
+$588M |
HCA, FMC, DOW, Q, ELV, CIXXXX |
13F-HR |
8/14/2017, 04:26 PM |
Q1 2017 |
52 |
$15.1B |
+$1.36B |
-$1.9B |
-$536M |
HCA, HUM, ELV, DOW, FMC, CIXXXX |
13F-HR |
5/15/2017, 04:23 PM |
Q4 2016 |
49 |
$14.8B |
+$2.8B |
-$1.58B |
+$1.22B |
HCA, HUM, ELV, CIXXXX, AET, GOOGL |
13F-HR |
2/14/2017, 03:25 PM |
Q3 2016 |
50 |
$14B |
+$2.14B |
-$960M |
+$1.18B |
HUM, HCA, CIXXXX, CBS, ELV, AET |
13F-HR |
11/14/2016, 03:20 PM |
Q2 2016 |
47 |
$14.1B |
+$1.7B |
-$759M |
+$942M |
HUM, HCA, MON, CIXXXX, ABBV, LH |
13F-HR |
8/15/2016, 04:10 PM |
Q1 2016 |
45 |
$13.7B |
+$478M |
-$2.51B |
-$2.04B |
HUM, HCA, MON, CIXXXX, ABBV, LH |
13F-HR |
5/16/2016, 04:11 PM |
Q4 2015 |
54 |
$17.8B |
+$2.84B |
-$2.42B |
+$417M |
HUM, MON, CIXXXX, HCA, TMO, ABBV |
13F-HR |
2/16/2016, 03:52 PM |
Q3 2015 |
78 |
$20.2B |
+$2.25B |
-$2.34B |
-$81.7M |
HUM, MON, TMO, ABBV, FLEX, CIXXXX |
13F-HR |
11/16/2015, 03:11 PM |
Q2 2015 |
81 |
$25.3B |
+$6.56B |
-$1.99B |
+$4.57B |
HUM, TMO, ABBV, MON, THC, FLEX |
13F-HR |
8/14/2015, 04:11 PM |
Q1 2015 |
80 |
$21.9B |
+$4.2B |
-$2.14B |
+$2.06B |
MON, FLEX, TMO, HUM, ELV, WOOF |
13F-HR |
5/15/2015, 04:18 PM |
Q4 2014 |
74 |
$20B |
+$3.14B |
-$1.5B |
+$1.64B |
TMO, MON, FLEX, THC, CYH, WOOF |
13F-HR |
2/17/2015, 03:13 PM |
Q3 2014 |
74 |
$19.1B |
+$4.14B |
-$1.47B |
+$2.67B |
TMO, MON, THC, FLEX, HCA, CYH |
13F-HR |
11/14/2014, 03:09 PM |
Q2 2014 |
69 |
$17.3B |
+$3.81B |
-$1.24B |
+$2.57B |
TMO, MON, FLEX, HCA, THC, HUM |
13F-HR |
8/14/2014, 04:14 PM |
Q1 2014 |
67 |
$15.3B |
+$4.31B |
-$1.34B |
+$2.96B |
TMO, MON, HCA, CCIXXXX, THC, HUM |
13F-HR |
5/15/2014, 04:10 PM |
Q4 2013 |
66 |
$14B |
|
|
|
TMO, HCA, THC, MON, CCIXXXX, HMA |
13F-HR |
2/14/2014, 03:20 PM |